Access practice tools, as well as industry leading news, customizable alerts, dockets, and primary content, including a comprehensive collection of case law, dockets, and regulations. Leverage...
By Tony Dutra
July 15— A steady increase in the rate at which challenges under the America Invents Act of 2011 are being denied suggests that patent owners are walking away with enforceable rights at least half the time.
Though owners still have a better shot at defending invalidity challenges in court, the difference between court and Patent Trial and Appeal Board results is narrowing.
Data from Bloomberg BNA's PTAB Challenge Navigator through May 31, 2016, show the board denied inter partes review (IPR) petitions—refusing to institute trials to review the patentability of claims on grounds of being not novel or obvious—at a rate of about 34 percent in the most recent year, and 29 percent in the preceding year. That compares to about 18 percent in the PTAB's early days.
For trials that proceed to the end, resulting in final written decisions (FWD), there has been a slight change in favor of patent owners. In the most recent full year of challenges that have gone to the end, 14.2 percent of final written decisions were complete victories for patent owners, with no claims cancelled. That compares to 11.9 percent for the AIA period—13 months—preceding that year.
Studies tend to focus on FWD results, ignoring decisions at earlier stages that aren't clear wins for petitioners.
For example, Federal Circuit Judge Pauline Newman, in a recent dissenting opinion, used data provided in an amicus brief by nine patent owners, led by 3M Co., to note that the PTAB rarely changes its mind after instituting trial. Newman added post-trial-start settlements and dismissals as losses to bring the 14.2 percent FWD full patent owner success rate down to 9 percent. For settlements, at least, common wisdom is that the patent owner is disadvantaged after trial institution; the settlement allows the patent owner to keep the patent but it is of little value going forward. See below for more on the topic.
But Newman's concern was that the same PTAB judges are instituting trial and writing FWDs. That concern of bias—that a judge's finding of a likelihood of unpatentability in order to institute trial makes a finding of unpatentability in the last decision not surprising—may either be addressed by the Supreme Court—Newman's colleagues on the Federal Circuit bench have rejected it—or by Congress. But it is a different question than whether patent owners are surviving IPR challenges with enforceable patents.
Beyond the FWD results, three years of AIA data offer results that can be interpreted as wins for patent owners:
As of May 31, there were 751 trials in progress and 666 petitions without trial institution decisions—fully one-third of the three-year total of challenges filed. It's unknown whether the board will follow recent trends in disposing of them.
It's also virtually impossible to calculate patent owner success rates for the rest of the cases—the completed two-thirds—because other factors are not known, including settlement values, how settlements affect future enforcement potential, and the value and potential of claims that survived split decisions.
However, even assuming that every settlement and split decision is a petitioner win, the success rate for patent owners would be 43 percent. If just one-fourth of the cases involve a patent owner win, with surviving claims having value and potential, the success rate climbs to 50 percent.
Regardless of whether that's a better or worse outcome than what a patent owner would get from a district court judge or jury, it certainly doesn't match the narrative of patent owner devastation at the PTAB.
To contact the reporter on this story: Tony Dutra in Washington at email@example.com
To contact the editor responsible for this story: Mike Wilczek in Washington at firstname.lastname@example.org
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)